Is there a role for rezafungin in intra-abdominal Candida spp. infections? A case series and literature review
Lucia Diella(Humanitas University), Michele Bartoletti(Humanitas University), Nadia Fusilli(IRCCS Humanitas Research Hospital), E Casari(IRCCS Humanitas Research Hospital), Davide Fiore Bavaro(Humanitas University), Debora Mondatore(IRCCS Humanitas Research Hospital), Martina Roperti(IRCCS Humanitas Research Hospital), Linda Bussini(University of Bologna), Chiara Verduci(IRCCS Humanitas Research Hospital), Massimo Vanoni(IRCCS Humanitas Research Hospital), Daniele Del Fabbro(IRCCS Humanitas Research Hospital), Maria Calabrò(IRCCS Humanitas Research Hospital), Maurizio Cecconi(Humanitas University), Dario Cattaneo(Humanitas University), Paola Morelli(IRCCS Humanitas Research Hospital), Pietro Gazzola(IRCCS Humanitas Research Hospital), Elena Costantini(IRCCS Humanitas Research Hospital), Gabriella Pieri(IRCCS Humanitas Research Hospital), Valeria Cento(Rostov State Medical University)
Cited by 0
Related Papers
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients
|Internal and Emergency Medicine|2022|113
Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives
|Antibiotics|2021|95
Multiclass <scp>HCV</scp> resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies
|Liver International|2017|90
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)
|Clinical Microbiology and Infection|2020|85